Strategies for discovering novel cancer biomarkers through utilization of emerging technologies V Kulasingam, EP Diamandis Nature clinical practice Oncology 5 (10), 588-599, 2008 | 892 | 2008 |
Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients VG Hall, VH Ferreira, T Ku, M Ierullo, B Majchrzak-Kita, C Chaparro, ... New England Journal of Medicine 385 (13), 1244-1246, 2021 | 548 | 2021 |
Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets V Kulasingam, EP Diamandis Molecular & cellular proteomics 6 (11), 1997-2011, 2007 | 241 | 2007 |
Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer V Kulasingam, MP Pavlou, EP Diamandis Nature Reviews Cancer 10 (5), 371-378, 2010 | 192 | 2010 |
Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines C Planque, V Kulasingam, CR Smith, K Reckamp, L Goodglick, ... Molecular & cellular proteomics 8 (12), 2746-2758, 2009 | 170 | 2009 |
Mining the Ovarian Cancer Ascites Proteome for Potential Ovarian Cancer Biomarkers* S C Kuk, V Kulasingam, CG Gunawardana, CR Smith, I Batruch, ... Molecular & Cellular Proteomics 8 (4), 661-669, 2009 | 163 | 2009 |
Quantitative measurement of anti-SARS-CoV-2 antibodies: analytical and clinical evaluation V Higgins, A Fabros, V Kulasingam Journal of clinical microbiology 59 (4), 10.1128/jcm. 03149-20, 2021 | 134 | 2021 |
Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients VG Hall, VH Ferreira, M Ierullo, T Ku, T Marinelli, B Majchrzak-Kita, ... American Journal of Transplantation 21 (12), 3980-3989, 2021 | 132 | 2021 |
Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma … B Krastins, A Prakash, DA Sarracino, D Nedelkov, EE Niederkofler, ... Clinical biochemistry 46 (6), 399-410, 2013 | 125 | 2013 |
Circulating tumor DNA as a cancer biomarker: fact or fiction? F Leung, V Kulasingam, EP Diamandis, DSB Hoon, K Kinzler, K Pantel, ... Clinical chemistry 62 (8), 1054-1060, 2016 | 107 | 2016 |
Tissue culture‐based breast cancer biomarker discovery platform V Kulasingam, EP Diamandis International journal of cancer 123 (9), 2007-2012, 2008 | 98 | 2008 |
“Product ion monitoring” assay for prostate-specific antigen in serum using a linear ion-trap V Kulasingam, CR Smith, I Batruch, A Buckler, DA Jeffery, EP Diamandis Journal of proteome research 7 (2), 640-647, 2008 | 96 | 2008 |
Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses VG Hall, VH Ferreira, H Wood, M Ierullo, B Majchrzak-Kita, K Manguiat, ... Nature Immunology 23 (3), 380-385, 2022 | 91 | 2022 |
Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assays A Prakash, T Rezai, B Krastins, D Sarracino, M Athanas, P Russo, ... Journal of proteome research 9 (12), 6678-6688, 2010 | 82 | 2010 |
Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer V Kulasingam, Y Zheng, A Soosaipillai, AE Leon, M Gion, EP Diamandis International journal of cancer 125 (1), 9-14, 2009 | 81 | 2009 |
Validation of a novel biomarker panel for the detection of ovarian cancer F Leung, MQ Bernardini, MD Brown, Y Zheng, R Molina, RC Bast Jr, ... Cancer Epidemiology, Biomarkers & Prevention 25 (9), 1333-1340, 2016 | 78 | 2016 |
Folate-receptor 1 (FOLR1) protein is elevated in the serum of ovarian cancer patients F Leung, A Dimitromanolakis, H Kobayashi, EP Diamandis, V Kulasingam Clinical biochemistry 46 (15), 1462-1468, 2013 | 77 | 2013 |
Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies A Prakash, T Rezai, B Krastins, D Sarracino, M Athanas, P Russo, ... Journal of proteome research 11 (8), 3986-3995, 2012 | 77 | 2012 |
Pediatric reference intervals for 28 chemistries and immunoassays on the Roche cobas® 6000 analyzer—A CALIPER pilot study V Kulasingam, BP Jung, IM Blasutig, S Baradaran, MK Chan, M Aytekin, ... Clinical biochemistry 43 (13-14), 1045-1050, 2010 | 67 | 2010 |
Urinary adenosine excretion in type 1 diabetes H Rajasekeran, Y Lytvyn, A Bozovic, JA Lovshin, E Diamandis, D Cattran, ... American Journal of Physiology-Renal Physiology 313 (2), F184-F191, 2017 | 63 | 2017 |